Investigating the phase-solubility and compatibility study of anticancer drug complexed with β-cyclodextrin and HP–β-cyclodextrin

Preeti Dhurve, Atul Tripathi, Bina Gidwani, Amber Vyas

DOI: http://dx.doi.org/10.5138/09761055.1929

Abstract


Poor  aqueous  solubility  and  dissolution  rates  are  critical  problems  that  hinders  the  formulation, development  and  delivery  of  most  of  BCS  class  II  and  class  IV  drugs.  Gefitinib  is  a  cytotoxic chemotherapeutic  drug  used  in  treatment  of  cancer.    The  objective  of  the  present  study  was  to investigate  the  drug-cyclodextrin  compatibility  study  by  FTIR  and  DSC  study.  The  phase solubility  study  revealed  formation  of  1:1  stoichiometry  binary  inclusion  complex.  The  complex was  prepared  by  kneading  method.  FT-IR  spectra  provided  the  data  indicating  that  the  HP-β-CD was  more  effective  than  β-CD.  Differential  scanning  calorimetry  thermograms  indicated  stronger amorphization and entrapment of  gefitinib with HP-β-CD.

Keywords


Keywords – gefitinib, cyclodextrins, complexation, DSC, FTIR.

References


Gidwani B, Vyas A. Synthesis, characterization and application of epichlorohydrin-βcyclodextrin polymer. Colloids and Surfaces B: Biointerfaces. 2014 Feb 1;114:130-7. 2. Del Valle EM. Cyclodextrins and their uses: a review. Process biochemistry. 2004 May 31;39(9):1033-46. 3. Eastburn SD, Tao BY. Applications of modified cyclodextrins. Biotechnol Adv 1994;12:325–39. 4. Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chemical reviews. 1998 Jul 30;98(5):2045-76. 5. Szejtli J. Past, present and futute of cyclodextrin research. Pure and Applied Chemistry. 2004 Jan 1;76(10):1825-45. 6. Yáñez C, Cañete-Rosales P, Castillo JP, Catalán N, Undabeytia T, Morillo E. Cyclodextrin inclusion complex to improve physicochemical properties of herbicide bentazon: exploring better formulations. PloS one. 2012 Aug 27;7(8):e41072. 7. T. Loftsson, H. Fridriksdottir, A.M. Sigurdardottir, The effect of water-soluble polymers on drug–cyclodextrin complexation, Int. J. Pharm. 110 (1994) 169–177. 8. D.O. Thompson, Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals, Crit. Rev. Ther. Drug Carrier Syst. 14 (1997) 01–104. 9. V.A. Ventura, S. Tirendi, G. Puglisi, E. Bousquet, Improvement of water solubility and dissolution rate of ursodeoxychilic acid and chenodeoxychilic acid by complexation with natural and modified cyclodextrins, Int. J. Pharm. 149 (1997) 1–13. 10. R.A. Rajewski, V.J. Stella, Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery, J. Pharm. Sci. 85 (1996) 1142–1169. 11. T. Irie, K. Uekama, Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation, J. Pharm. Sci. 86 (1997) 147–162. 12. E.B. Marcus, V. Roger, J. Peeters, N. Peter, V. Geert, L. Thorsteinn, Comparative interaction of 2-hydroxypropyl--cyclodextrin and sulfobutylether-- cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions, Eur. J. Pharm. Sci. 34 (2008) 94–103. 13. J. Peeter, P. Neeskens, J. Adriaensen, M. Brewster, Effect of temperature on complexation with 2-hydroxypropyl--cyclodextrin, J. Incl. Phenom. Mol. 44 (2002) 7577. 14. O. Robert, M. Vorapann, S. Mongkol, Characterization of an inclusion complex of cholesterol and hydroxypropyl--cyclodextrin, Eur. J. Pharm. Biopharm. 46 (1998) 355360. 15. J. Savolainen, K. Jarvinun, L. Matilainen, Improved dissolution and bioavailability of phenytoin by sulfobutylether-cyclodextrin ((SBE) 7m-CD) and hydroxypropyl-cyclodextrin (HP--CD) complexation, Int. J. Pharm. 165 (1998) 69–78. 16. Jangde R, Singhour R, Daharwal SJ. Compatibility studies Between Gatifloxacin and Pharmaceutical excipients through Differential Scanning Calorimetry and Infra red Spectroscopy. Research J. Pharma. Dosage forms Tech. 2010; 2(1): 103-106. 17. Jug M, Francesca M, Marco B, Paola M. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Journal of Pharmaceutical and Biomed Analysis 2010; 52: 9–18. 18. Riekes MK, Tagliari MP, Granada A, Kuminek G, Silva MAS, Stulzer HK. Enhanced solubility and dissolution rate of amiodarone by complexation with β-cyclodextrin through different methods. Material Science and Engineering C 2010; 30: 1008–1013.


Refbacks

  • There are currently no refbacks.
';



Copyright (c) 2018 Preeti Dhruve, Atul Tripathi , Bina Gidwani , Amber Vyas

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

              AR Journals

18K, Street 1st, Gaytri Vihar, Pinto Park, Gwalior, M.P. India

       Copyright@arjournals.org (Design) 2009-2018

 

Follow @arjournals on Twitter